Display advertising improves the visibility of your products and services among specialists in your field. Taylor & Francis Group offers a large range of journals with focused readership. Many of our journals are affiliated with prestigious societies and are distributed to their membership. Contact us for advertising rates, premium placement and the range of services we can offer.
Taylor & Francis Journals Advertising Policy
All advertisements are subject to approval of the Publisher, Editor, or publishing partner of Taylor & Francis which reserves the right to reject or cancel any advertisement at any time. Advertising content for tobacco, alcohol, recreational drugs or any illegal products will not be accepted.
Statements in advertisements should carry no direct or implied disparagement of another product. There should be no statements that are misleading, exaggerated, or contrary to proven facts. Advertisements may not be indecent, obscene, or defamatory.
The principle of maintaining editorial independence from commercial influence underlies decision-making. Editorial decisions are not influenced by advertising.
Advertisements must be clearly identifiable as advertisements and clearly distinguishable from editorial content. Taylor & Francis will not publish advertisements in the form of editorial content. Sponsored supplements must be clearly indicated as such.
Taylor & Francis will not sell treatment-specific or drug-specific advertising on the condition that it is displayed adjacent to a specific article mentioning that product in print. Online advertising may be targeted by subject and does not appear on the PDF version of articles.
All advertisements must clearly and prominently identify the advertiser by trademark or signature. Print advertising features must carry the statement “Advertising Feature” in a font size at least one-half that of the largest font size used in the advertisement.
Advertised products must be compliant with the regulations in the country where the advertisement will be seen. If advertising content has been approved by a relevant Regulatory Body, such as for example the Medicines and Healthcare products Regulatory Agency (MHRA) or the Food and Drug Administration (FDA), it will normally be accepted without changes.